Arvee Laborat.

Market Cap: Micro Cap
Industry: Chemicals & Petrochemicals
ISIN: INE006Z01016
NSEID: ARVEE
BSEID:

INR

210.51

35.08 (20.0%)

BSENSE

Dec 17

BSE+NSE Vol: 121962

{
  "main_header": {
    "sid": 1002931,
    "name": "Arvee Laborat.",
    "stock_name": "Arvee Laborat.",
    "full_name": "Arvee Laboratories (India) Ltd",
    "name_url": "stocks-analysis/arvee-laborat",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "210.51",
    "chg": 35.08,
    "chgp": "20.0%",
    "dir": 1,
    "prev_price": "175.43",
    "mcapval": "224.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "ARVEE",
    "ind_name": "Chemicals & Petrochemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE006Z01016",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": 121962,
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/arvee-laborat-1002931-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Arvee Laboratories (India) Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arvee-laboratories-surges-20-to-hit-upper-circuit-amid-strong-buying-pressure-3761294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ArveeLaboratori_stocks_hitting_upper_circuit_3761294.png",
        "date": "2025-12-17 11:00:17",
        "description": "Shares of Arvee Laboratories (India) Ltd surged to their upper circuit limit on 17 Dec 2025, reflecting intense buying interest and a maximum permissible daily gain of 20%. The stock closed at ₹210.51, marking a significant move within the Chemicals & Petrochemicals sector, while broader indices such as the Sensex and the sector itself recorded marginal declines."
      },
      {
        "title": "Why is Arvee Laborat. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-arvee-laborat-fallingrising-3749669",
        "imagepath": "",
        "date": "2025-12-06 01:41:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Robust Price Performance Against Benchmarks</strong></p>\n<p>Arvee Laboratories has demonstrated remarkable stock price appreciation over various time frames, substantially outperforming the broader market indices. Over the past week, the stock surged by 23.01%, while the Sensex remained virtually flat with a marginal decline of 0.06%. This momentum extends to the one-month period, where Arvee's gains of 23.58% far outpaced the Sensex's 2.30% rise. Year-to-date, the stock has delivered a 13.64% return compared to the Sensex's 10.75%, and over the last year, it has appreciated by 15.57%, more than doubling the benchmark's 5.98% increase. The three-year and five-year returns are even more striking, with Arvee Laboratories posting gains of 72.25% and 375.86% respectively, dwarfing the Sensex's 4..."
      },
      {
        "title": "Arvee Laboratories (India) Sees Extraordinary Buying Interest, Hits Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arvee-laboratories-surges-on-unprecedented-buying-interest-amid-upper-circuit-lock-3748775",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ArveeLaboratori_only_buyers_3748775.png",
        "date": "2025-12-05 10:46:01",
        "description": "Arvee Laboratories (India) Ltd has witnessed an exceptional surge in buying activity, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense investor interest and suggests the possibility of a sustained multi-day circuit scenario."
      },
      {
        "title": "Arvee Laboratories (India) Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arvee-laboratories-surges-193-to-hit-upper-circuit-amid-strong-buying-pressure-3748501",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ArveeLaboratori_stocks_hitting_upper_circuit_3748501.png",
        "date": "2025-12-05 10:00:31",
        "description": "Shares of Arvee Laboratories (India) Ltd surged to hit the upper circuit limit on 5 December 2025, reflecting intense buying interest and a maximum permissible daily gain of 19.62%. The stock closed at ₹196.92, marking a significant move in the Chemicals & Petrochemicals sector, while broader market indices showed muted activity."
      },
      {
        "title": "Arvee Laborat. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/arvee-laborat-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3746510",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ArveeLaborat_mojoScore_3746510.png",
        "date": "2025-12-04 11:08:06",
        "description": "Arvee Laborat., a microcap player in the Chemicals & Petrochemicals sector, has undergone a notable revision in its market evaluation metrics, reflecting a shift in analytical perspective driven by recent financial and technical developments."
      },
      {
        "title": "Arvee Laboratories' Quality Grade Change Reflects Financial Challenges and Competitive Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/arvee-laboratories-downgraded-to-below-average-quality-grade-amid-declining-financial-metrics-3710025",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArveeLaboratori_qualitydot_3710025.png",
        "date": "2025-11-18 08:01:49",
        "description": "Arvee Laboratories (India), a microcap in the Chemicals & Petrochemicals sector, has faced challenges with a slight decline in sales and a significant drop in EBIT growth. However, it maintains a solid EBIT to interest ratio and low debt levels, with competitive performance metrics compared to industry peers."
      },
      {
        "title": "How has been the historical performance of Arvee Laborat.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-arvee-laborat-3709168",
        "imagepath": "",
        "date": "2025-11-17 23:21:56",
        "description": "Answer:\nThe historical performance of Arvee Laborat shows significant fluctuations in key financial metrics over the years.\n\nBreakdown:\nArvee Laborat's net sales have varied considerably, peaking at 62.48 Cr in March 2023 before declining to 38.49 Cr in March 2025. The total operating income followed a similar trend, reaching its highest at 62.48 Cr in March 2023 and dropping to 38.49 Cr in March 2025. The raw material cost has also seen an increase, from 18.87 Cr in March 2025 compared to 16.98 Cr in March 2024, while total expenditure excluding depreciation decreased from 54.07 Cr in March 2023 to 34.87 Cr in March 2025. Operating profit (PBDIT) has fluctuated, with a high of 8.63 Cr in March 2023 and a decrease to 4.28 Cr in March 2025. Profit before tax showed a decline from 6.17 Cr in March 2023 to 2.87 Cr in March 2025, while profit after tax also decreased from 4.12 Cr in March 2023 to 2.15 Cr in Mar..."
      },
      {
        "title": "Arvee Laboratories Q2 FY26: Revenue Plunges 72% as Profit Margins Collapse",
        "link": "https://www.marketsmojo.com/news/result-analysis/arvee-laboratories-q2-fy26-revenue-plunges-72-as-profit-margins-collapse-3708075",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ArveeLaboratori_quaterlyResult_3708075.png",
        "date": "2025-11-17 19:48:14",
        "description": "Arvee Laboratories (India) Ltd., an Ahmedabad-based specialised chemicals manufacturer, reported deeply concerning Q2 FY26 results that signal severe operational distress. Net profit collapsed to just ₹0.01 crores from ₹0.98 crores in Q2 FY25, representing a staggering 98.98% year-on-year decline. The micro-cap company, with a market capitalisation of ₹191.00 crores, saw its stock trade at ₹167.57, up 2.52% following the results announcement, though this modest uptick does little to offset the fundamental deterioration evident in the quarterly numbers."
      },
      {
        "title": "How has been the historical performance of Arvee Laborat.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-arvee-laborat-3703991",
        "imagepath": "",
        "date": "2025-11-15 00:21:21",
        "description": "Answer:\nThe historical performance of Arvee Laborat shows fluctuations in key financial metrics over the years.\n\nBreakdown:\nArvee Laborat's net sales have varied significantly, peaking at 62.48 Cr in March 2023 and declining to 38.49 Cr by March 2025. The total operating income followed a similar trend, with a high of 62.48 Cr in March 2023 and a drop to 38.49 Cr in March 2025. Total expenditure, excluding depreciation, also saw a decrease from 54.07 Cr in March 2023 to 34.87 Cr in March 2025. Operating profit (PBDIT) reached its highest at 8.63 Cr in March 2023 but fell to 4.28 Cr by March 2025. Profit before tax mirrored this decline, dropping from 6.17 Cr in March 2023 to 2.87 Cr in March 2025, while profit after tax decreased from 4.12 Cr to 2.15 Cr in the same period. The company's earnings per share (EPS) showed a decline from 3.74 in March 2023 to 1.95 in March 2025. On the balance sheet, total liabi..."
      }
    ],
    "total": 379,
    "sid": "1002931",
    "stock_news_url": "https://www.marketsmojo.com/news/arvee-laboratories-india-1002931"
  },
  "announcements": [
    {
      "details": "Arvee Laboratories (India) Limitedies (India) Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Arvee Laboratories (India) Limited - Clarification - Financial Results",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Arvee Laboratories (India) Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Arvee Laboratories (India) Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Arvee Laboratories (India) Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 13 Oct 20",
          "dt": "2020-10-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Arvee Laboratories (India) Hits Upper Circuit Amid Strong Buying Pressure

2025-12-17 11:00:17

Shares of Arvee Laboratories (India) Ltd surged to their upper circuit limit on 17 Dec 2025, reflecting intense buying interest and a maximum permissible daily gain of 20%. The stock closed at ₹210.51, marking a significant move within the Chemicals & Petrochemicals sector, while broader indices such as the Sensex and the sector itself recorded marginal declines.

Why is Arvee Laborat. falling/rising?

2025-12-06 01:41:46

Robust Price Performance Against Benchmarks

Arvee Laboratories has demonstrated remarkable stock price appreciation over various time frames, substantially outperforming the broader market indices. Over the past week, the stock surged by 23.01%, while the Sensex remained virtually flat with a marginal decline of 0.06%. This momentum extends to the one-month period, where Arvee's gains of 23.58% far outpaced the Sensex's 2.30% rise. Year-to-date, the stock has delivered a 13.64% return compared to the Sensex's 10.75%, and over the last year, it has appreciated by 15.57%, more than doubling the benchmark's 5.98% increase. The three-year and five-year returns are even more striking, with Arvee Laboratories posting gains of 72.25% and 375.86% respectively, dwarfing the Sensex's 4...

Arvee Laboratories (India) Sees Extraordinary Buying Interest, Hits Upper Circuit

2025-12-05 10:46:01

Arvee Laboratories (India) Ltd has witnessed an exceptional surge in buying activity, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense investor interest and suggests the possibility of a sustained multi-day circuit scenario.

Arvee Laboratories (India) Hits Upper Circuit Amid Strong Buying Pressure

2025-12-05 10:00:31

Shares of Arvee Laboratories (India) Ltd surged to hit the upper circuit limit on 5 December 2025, reflecting intense buying interest and a maximum permissible daily gain of 19.62%. The stock closed at ₹196.92, marking a significant move in the Chemicals & Petrochemicals sector, while broader market indices showed muted activity.

Arvee Laborat. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-04 11:08:06

Arvee Laborat., a microcap player in the Chemicals & Petrochemicals sector, has undergone a notable revision in its market evaluation metrics, reflecting a shift in analytical perspective driven by recent financial and technical developments.

Arvee Laboratories' Quality Grade Change Reflects Financial Challenges and Competitive Positioning

2025-11-18 08:01:49

Arvee Laboratories (India), a microcap in the Chemicals & Petrochemicals sector, has faced challenges with a slight decline in sales and a significant drop in EBIT growth. However, it maintains a solid EBIT to interest ratio and low debt levels, with competitive performance metrics compared to industry peers.

How has been the historical performance of Arvee Laborat.?

2025-11-17 23:21:56

Answer: The historical performance of Arvee Laborat shows significant fluctuations in key financial metrics over the years. Breakdown: Arvee Laborat's net sales have varied considerably, peaking at 62.48 Cr in March 2023 before declining to 38.49 Cr in March 2025. The total operating income followed a similar trend, reaching its highest at 62.48 Cr in March 2023 and dropping to 38.49 Cr in March 2025. The raw material cost has also seen an increase, from 18.87 Cr in March 2025 compared to 16.98 Cr in March 2024, while total expenditure excluding depreciation decreased from 54.07 Cr in March 2023 to 34.87 Cr in March 2025. Operating profit (PBDIT) has fluctuated, with a high of 8.63 Cr in March 2023 and a decrease to 4.28 Cr in March 2025. Profit before tax showed a decline from 6.17 Cr in March 2023 to 2.87 Cr in March 2025, while profit after tax also decreased from 4.12 Cr in March 2023 to 2.15 Cr in Mar...

Arvee Laboratories Q2 FY26: Revenue Plunges 72% as Profit Margins Collapse

2025-11-17 19:48:14

Arvee Laboratories (India) Ltd., an Ahmedabad-based specialised chemicals manufacturer, reported deeply concerning Q2 FY26 results that signal severe operational distress. Net profit collapsed to just ₹0.01 crores from ₹0.98 crores in Q2 FY25, representing a staggering 98.98% year-on-year decline. The micro-cap company, with a market capitalisation of ₹191.00 crores, saw its stock trade at ₹167.57, up 2.52% following the results announcement, though this modest uptick does little to offset the fundamental deterioration evident in the quarterly numbers.

How has been the historical performance of Arvee Laborat.?

2025-11-15 00:21:21

Answer: The historical performance of Arvee Laborat shows fluctuations in key financial metrics over the years. Breakdown: Arvee Laborat's net sales have varied significantly, peaking at 62.48 Cr in March 2023 and declining to 38.49 Cr by March 2025. The total operating income followed a similar trend, with a high of 62.48 Cr in March 2023 and a drop to 38.49 Cr in March 2025. Total expenditure, excluding depreciation, also saw a decrease from 54.07 Cr in March 2023 to 34.87 Cr in March 2025. Operating profit (PBDIT) reached its highest at 8.63 Cr in March 2023 but fell to 4.28 Cr by March 2025. Profit before tax mirrored this decline, dropping from 6.17 Cr in March 2023 to 2.87 Cr in March 2025, while profit after tax decreased from 4.12 Cr to 2.15 Cr in the same period. The company's earnings per share (EPS) showed a decline from 3.74 in March 2023 to 1.95 in March 2025. On the balance sheet, total liabi...

View All News

Announcement

Arvee Laboratories (India) Limited - Clarification - Financial Results

03-Dec-2019 | Source : NSE

Arvee Laboratories (India) Limitedies (India) Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.